Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ridong Li

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Biochemical and Biophysical Research Communications|February 4, 2015
LRD-22, a novel dual dithiocarbamatic acid ester, inhibits Aurora-A kinase and induces apoptosis and cell cycle arrest in HepG2 cellsHuiling Wang, Ridong Li, Li Li, et al.
European Journal of Medicinal Chemistry|June 10, 2019
Synthesis and anti-tumor efficacy of novel 2, 4-diarylaminopyrimidine derivatives bearing N-(3-pyridinylmethyl) urea moiety as anaplastic lymphoma kinase inhibitorsHong Chen, Ridong Li, Xianling Ning, et al.
Free Radical Biology & Medicine|January 23, 2025
Identification of a novel cuproptosis inducer that induces ER stress and oxidative stress to trigger immunogenic cell death in tumorsXianling Ning, Xi Chen, Ridong Li, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 30, 2017
Synthesis and antitumor activity of novel 2, 3-didithiocarbamate substituted naphthoquinones as inhibitors of pyruvate kinase M2 isoformXianling Ning, Hailong Qi, Ridong Li, et al.
Future Medicinal Chemistry|June 24, 2022
Discovery of novel PRMT5 inhibitors bearing a methylpiperazinyl moietyXinyu Bai, Zheng Zhai, Xuyang Zhao, et al.
Bioorganic Chemistry|January 31, 2021
Synthesis of novel sulfonamide derivatives containing pyridin-3-ylmethyl 4-(benzoyl)piperazine-1-carbodithioate moiety as potent PKM2 activatorsRidong Li, Xianling Ning, Jianan He, et al.
Archiv Der Pharmazie|November 28, 2012
Novel dithiocarbamic acid esters derived from 6-aminomethyl-4-anilinoquinazolines and 6-aminomethyl-4-anilino-3-cyanoquinolines as potent EGFR inhibitorsXin Zhang, Ridong Li, Kang Qiao, et al.
The Journal of Organic Chemistry|July 22, 2020
Design, Synthesis, and Resolution of Spirocyclic Bisoxindole-Based C<sub>2</sub>-Symmetric DiolsGuodong Sun, Zhongqing Wang, Zhonghua Luo, et al.
Medchemcomm|August 16, 2018
Anti-cancer effect of a novel 2,3-didithiocarbamate-substituted naphthoquinone as a tumor metabolic suppressor <i>in vitro</i> and <i>in vivo</i>Xianling Ning, Yunqiao Li, Hailong Qi, et al.
Drug Delivery|February 27, 2020
Erythrocyte-mimicking paclitaxel nanoparticles for improving biodistributions of hydrophobic drugs to enhance antitumor efficacyZheng Zhai, Pengcheng Xu, Jun Yao, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Biochemical and Biophysical Research Communications|February 4, 2015
LRD-22, a novel dual dithiocarbamatic acid ester, inhibits Aurora-A kinase and induces apoptosis and cell cycle arrest in HepG2 cellsHuiling Wang, Ridong Li, Li Li, et al.
European Journal of Medicinal Chemistry|June 10, 2019
Synthesis and anti-tumor efficacy of novel 2, 4-diarylaminopyrimidine derivatives bearing N-(3-pyridinylmethyl) urea moiety as anaplastic lymphoma kinase inhibitorsHong Chen, Ridong Li, Xianling Ning, et al.
Free Radical Biology & Medicine|January 23, 2025
Identification of a novel cuproptosis inducer that induces ER stress and oxidative stress to trigger immunogenic cell death in tumorsXianling Ning, Xi Chen, Ridong Li, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 30, 2017
Synthesis and antitumor activity of novel 2, 3-didithiocarbamate substituted naphthoquinones as inhibitors of pyruvate kinase M2 isoformXianling Ning, Hailong Qi, Ridong Li, et al.
Future Medicinal Chemistry|June 24, 2022
Discovery of novel PRMT5 inhibitors bearing a methylpiperazinyl moietyXinyu Bai, Zheng Zhai, Xuyang Zhao, et al.
Bioorganic Chemistry|January 31, 2021
Synthesis of novel sulfonamide derivatives containing pyridin-3-ylmethyl 4-(benzoyl)piperazine-1-carbodithioate moiety as potent PKM2 activatorsRidong Li, Xianling Ning, Jianan He, et al.
Archiv Der Pharmazie|November 28, 2012
Novel dithiocarbamic acid esters derived from 6-aminomethyl-4-anilinoquinazolines and 6-aminomethyl-4-anilino-3-cyanoquinolines as potent EGFR inhibitorsXin Zhang, Ridong Li, Kang Qiao, et al.
The Journal of Organic Chemistry|July 22, 2020
Design, Synthesis, and Resolution of Spirocyclic Bisoxindole-Based C<sub>2</sub>-Symmetric DiolsGuodong Sun, Zhongqing Wang, Zhonghua Luo, et al.
Medchemcomm|August 16, 2018
Anti-cancer effect of a novel 2,3-didithiocarbamate-substituted naphthoquinone as a tumor metabolic suppressor <i>in vitro</i> and <i>in vivo</i>Xianling Ning, Yunqiao Li, Hailong Qi, et al.
Drug Delivery|February 27, 2020
Erythrocyte-mimicking paclitaxel nanoparticles for improving biodistributions of hydrophobic drugs to enhance antitumor efficacyZheng Zhai, Pengcheng Xu, Jun Yao, et al.
Pageof 4